Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study.

At Day 56, FCM-associated improvement was significantly better for contentment and showed a trend for calmness ( table 3 , fig. 2D ).

also in 53,322 other papers

While the study’s primary endpoint (decrease in fatigue 6 weeks after treatment initiation) did not reach statistical significance vs. placebo, post-hoc analyses demonstrated a significant effect on fatigue.

also in 111,027 other papers